BiomarkersHumans439 healthy adultsCohort study

Age-linked immune endotypes are associated with COPD risk

In 89 adults, high- and moderate-inflammatory endotypes had adjusted odds ratios of 17.2 and 7.1 for COPD high-risk status versus a low-inflammatory group.

Figure 1. Study flow diagram. Flow diagram of participant selection in the discovery and validation cohorts.
Open the figure at full size
Figure 1. Study flow diagram. Flow diagram of participant selection in the discovery and validation cohorts.Study flow diagram. Flow diagram of participant selection in the discovery and validation cohorts.Wu et al. · CC BY-NC

Journal of Inflammation Research

In a study of human adults, researchers investigated age-associated immune biomarkers to identify distinct inflammatory profiles linked to early chronic obstructive pulmonary disease (COPD) risk. A discovery cohort of 439 healthy adults helped identify four cytokines—IL-4, IL-5, IL-6, and IL-12p70—that correlated with age and were elevated in individuals at high risk for COPD. In a validation cohort of 89 community-dwelling adults, unsupervised clustering separated participants into three groups: high-, moderate-, and low-inflammatory endotypes. High-risk status, defined by questionnaire scores despite preserved lung function, was present in all 13 adults in the high-inflammatory cluster, 89.7% of the 29 moderate-inflammatory adults, and 35.6% of the 45 low-inflammatory adults. After adjusting for age and sex, the high-inflammatory endotype showed an odds ratio of 17.2 (95% CI: 4.7–63.0) and the moderate-inflammatory endotype showed an odds ratio of 7.1 (95% CI: 2.2–22.8) for high-risk status compared to the low-inflammatory endotype.

Why it matters

The findings highlight biological heterogeneity in immunosenescence and suggest that age-related immune remodeling may cluster into distinct profiles tied to early pulmonary disease risk.

Caveats

The observational design cannot evaluate causality, and the analyzed cytokines were preselected because they differed between groups. In addition, the validation cohort was relatively small, with high-risk status determined by a screening questionnaire rather than a clinical diagnosis.

The paper

Identification of Immune-Inflammatory Endotypes in Early COPD Risk: A Cluster Analysis of Age-Associated Biomarkers

Shanghai Medical College of Fudan University

Journal of Inflammation Research · 22 Sep 2026 · CC BY-NC

doi.org/10.2147/jir.s613590PubMed 42801161